Top
Comparison of treatments for the prevention of fetal growth restriction in obstetric antiphospholipid syndrome: a systematic review and network meta-analysis
Internal and Emergency Medicine
Comparison of treatments for the prevention of fetal growth restriction in obstetric antiphospholipid syndrome: a systematic review and network meta-analysis
DOI: 10.1007/s11739-020-02609-4, Volume: 16, Issue: 5, Pages: 1357-1367
Article Type: review-article,
Article History
received: 2020-10-5
accepted: 2020-12-14
published: 2021-1-21
Altmetric
https://www.researchpad.co/tools/openurl?pubtype=&doi=10.1007/s11739-020-02609-4&title=Comparison of treatments for the prevention of fetal growth restriction in obstetric antiphospholipid syndrome: a systematic review and network meta-analysis&author=&keyword=[{keywordId=4898, uniqueName=network-meta-analysis, name=Network meta-analysis, contentId=293746}, {keywordId=9976, uniqueName=heparin, name=heparin, contentId=293746}, {keywordId=12807, uniqueName=aspirin, name=aspirin, contentId=293746}, {keywordId=17360, uniqueName=antiphospholipid-syndrome, name=Antiphospholipid syndrome, contentId=293746}, {keywordId=55240, uniqueName=fetal-growth-restriction, last=true, name=fetal growth restriction, contentId=293746}],[{keywordId=4898, uniqueName=network-meta-analysis, name=Network meta-analysis, contentId=293746}, {keywordId=9976, uniqueName=heparin, name=heparin, contentId=293746}, {keywordId=12807, uniqueName=aspirin, name=aspirin, contentId=293746}, {keywordId=17360, uniqueName=antiphospholipid-syndrome, name=Antiphospholipid syndrome, contentId=293746}, {keywordId=55240, uniqueName=fetal-growth-restriction, last=true, name=fetal growth restriction, contentId=293746}],[{keywordId=4898, uniqueName=network-meta-analysis, name=Network meta-analysis, contentId=293746}, {keywordId=9976, uniqueName=heparin, name=heparin, contentId=293746}, {keywordId=12807, uniqueName=aspirin, name=aspirin, contentId=293746}, {keywordId=17360, uniqueName=antiphospholipid-syndrome, name=Antiphospholipid syndrome, contentId=293746}, {keywordId=55240, uniqueName=fetal-growth-restriction, last=true, name=fetal growth restriction, contentId=293746}],[{keywordId=4898, uniqueName=network-meta-analysis, name=Network meta-analysis, contentId=293746}, {keywordId=9976, uniqueName=heparin, name=heparin, contentId=293746}, {keywordId=12807, uniqueName=aspirin, name=aspirin, contentId=293746}, {keywordId=17360, uniqueName=antiphospholipid-syndrome, name=Antiphospholipid syndrome, contentId=293746}, {keywordId=55240, uniqueName=fetal-growth-restriction, last=true, name=fetal growth restriction, contentId=293746}],[{keywordId=4898, uniqueName=network-meta-analysis, name=Network meta-analysis, contentId=293746}, {keywordId=9976, uniqueName=heparin, name=heparin, contentId=293746}, {keywordId=12807, uniqueName=aspirin, name=aspirin, contentId=293746}, {keywordId=17360, uniqueName=antiphospholipid-syndrome, name=Antiphospholipid syndrome, contentId=293746}, {keywordId=55240, uniqueName=fetal-growth-restriction, last=true, name=fetal growth restriction, contentId=293746}],&subject=
Get the app for your Mobile or Tablet!
© 2024 Newgen KnowledgeWorks |
Privacy & Cookie Policy | Powered by: Nova